Our aspiration is to be part of the step-by-step progress continually being made against cancer. These advances make an important difference in the lives of patients. But, we won’t be satisfied until cures are found and the threat is removed. People who battle cancer deserve no less.
Networks
4604 Chicago Ave Minneapolis, MN 55407 Telephone: 612-822-0500 E-mail: [email protected]: http://mnovarian.org/
At Minoryx, we are committed to finding innovative treatments for life threatening rare diseases. We are currently focused on Inborn Errors of Metabolism, a group of rare diseases of genetic origin with high unmet medical need. Such diseases are life threatening and highly debilitating, usually with neurological manifestations and affect...
MitoAction is a nonprofit organization founded by patients, parents, and Boston hospital healthcare leaders who had a vision of improving quality of life for children and adults with mitochondrial disease. The organization began in 2005 as an idea and has evolved from a small New England support group to a...
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery and development of therapeutic radiopharmaceuticals and targeted molecular imaging agents for use in oncology and cardiology.
mondoBIOTECH is a research institution and develops solutions for rare diseases. mondoBIOTECH shares science through new technologies. mondoBIOTECH is an instrument – long term oriented – to change the world of medicine in rare diseases.
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in...
Since 1994, our MPD-SUPPORT web site and free support email list offers interesting information on chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, myelodysplasia, and myelofibrosis. Anyone – patient, family member, or health professional, is welcome to join our growing list of subscribers. Our archives are available for...
Founded by patients for patients, the MPN Research Foundation is a catalyst for research funding in pursuit of new treatments – and eventually a cure – for myeloproliferative neoplasms (MPNs). To date, we have funded more than $11 million in MPN research. 180 N. Michigan Avenue Suite 1870 Chicago, IL...